Nicotine therapeutic benefits: Difference between revisions

Jump to navigation Jump to search
(adding content)
(formatting)
Line 1,354: Line 1,354:


===2022: [https://pubmed.ncbi.nlm.nih.gov/35869375/ Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV]===
===2022: [https://pubmed.ncbi.nlm.nih.gov/35869375/ Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV]===


===2016: [https://truthinitiative.org/sites/default/files/media/files/2019/08/ReThinking-Nicotine_0.pdf Re-thinking nicotine and its effects]===
===2016: [https://truthinitiative.org/sites/default/files/media/files/2019/08/ReThinking-Nicotine_0.pdf Re-thinking nicotine and its effects]===


===2013: [https://journals.asm.org/doi/10.1128/cvi.00636-12?permanently=true Targeting the “Cytokine Storm” for Therapeutic Benefit]===
===2013: [https://journals.asm.org/doi/10.1128/cvi.00636-12?permanently=true Targeting the “Cytokine Storm” for Therapeutic Benefit]===


===2006: [https://www.academia.edu/17983526/The_reinforcing_effects_of_nicotine_and_stimulant_medication_in_the_everyday_lives_of_adult_smokers_with_ADHD_A_preliminary_examination  The reinforcing effects of nicotine and stimulantmedication in the everyday lives of adult smokerswith ADHD: A preliminary examination]===
===2006: [https://www.academia.edu/17983526/The_reinforcing_effects_of_nicotine_and_stimulant_medication_in_the_everyday_lives_of_adult_smokers_with_ADHD_A_preliminary_examination  The reinforcing effects of nicotine and stimulantmedication in the everyday lives of adult smokerswith ADHD: A preliminary examination]===


===2022: [https://pubmed.ncbi.nlm.nih.gov/35844833/ Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson's Disease]===
===2022: [https://pubmed.ncbi.nlm.nih.gov/35844833/ Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson's Disease]===
*Insect Study
*Insect Study


===2022: [https://www.frontiersin.org/articles/10.3389/fpsyt.2022.804055/full Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence]===
===2022: [https://www.frontiersin.org/articles/10.3389/fpsyt.2022.804055/full Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence]===
[https://twitter.com/hbwardMD/status/1487037135299518474 Twitter thread by one of the Authors]
[https://twitter.com/hbwardMD/status/1487037135299518474 Twitter thread by one of the Authors]


===see this [https://twitter.com/hbwardMD/status/1487037135299518474 thread] about nicotine and schizophrenia===
===see this [https://twitter.com/hbwardMD/status/1487037135299518474 thread] about nicotine and schizophrenia===


===2012: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444372/ Randomized controlled trial to evaluate tooth stain reduction with nicotine replacement gum during a smoking cessation program]===
===2012: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444372/ Randomized controlled trial to evaluate tooth stain reduction with nicotine replacement gum during a smoking cessation program]===


===2022: [https://assets.researchsquare.com/files/rs-1062121/v1/fb8f5195-4cce-470f-9e09-e752fae3c931.pdf?c=1642705044 Part One: Abuse Liability of Vuse Solo Relative To Combustible Cigarettes And Nicotine Gum]===
===2022: [https://assets.researchsquare.com/files/rs-1062121/v1/fb8f5195-4cce-470f-9e09-e752fae3c931.pdf?c=1642705044 Part One: Abuse Liability of Vuse Solo Relative To Combustible Cigarettes And Nicotine Gum]===


===2014: [https://link.springer.com/chapter/10.1007/978-1-4939-1167-7_20 Nicotinic Receptors and Mental Illness]=== <!--T:310-->
===2014: [https://link.springer.com/chapter/10.1007/978-1-4939-1167-7_20 Nicotinic Receptors and Mental Illness]=== <!--T:310-->


===2021: [https://pubmed.ncbi.nlm.nih.gov/34757527/ Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia]=== <!--T:279-->
===2021: [https://pubmed.ncbi.nlm.nih.gov/34757527/ Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia]=== <!--T:279-->


===2012: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286320/ Nicotine Reduces Antipsychotic-Induced Orofacial Dyskinesia in Rats]=== <!--T:280-->
===2012: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286320/ Nicotine Reduces Antipsychotic-Induced Orofacial Dyskinesia in Rats]=== <!--T:280-->
Line 1,393: Line 1,381:
<!--T:281-->
<!--T:281-->
*Animal
*Animal


===2021: [https://www.sciencedirect.com/science/article/abs/pii/S1001841721007804 Real-time effects of nicotine exposure and withdrawal on neurotransmitter metabolism of hippocampal neuronal cells by microfluidic chip-coupled LC-MS]=== <!--T:282-->
===2021: [https://www.sciencedirect.com/science/article/abs/pii/S1001841721007804 Real-time effects of nicotine exposure and withdrawal on neurotransmitter metabolism of hippocampal neuronal cells by microfluidic chip-coupled LC-MS]=== <!--T:282-->
Line 1,399: Line 1,386:
<!--T:283-->
<!--T:283-->
*mouse study
*mouse study


===2021: [https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006219.pub4/full Interventions for preventing weight gain after smoking cessation]=== <!--T:284-->
===2021: [https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006219.pub4/full Interventions for preventing weight gain after smoking cessation]=== <!--T:284-->
Line 1,405: Line 1,391:
<!--T:285-->
<!--T:285-->
*There was moderate‐certainty that NRT reduced weight at end of treatment and moderate‐certainty that the effect may be similar at 12 months, although the estimates are too imprecise to assess long‐term benefit.
*There was moderate‐certainty that NRT reduced weight at end of treatment and moderate‐certainty that the effect may be similar at 12 months, although the estimates are too imprecise to assess long‐term benefit.


===2004: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526783/ Nicotine as Therapy]=== <!--T:286-->
===2004: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526783/ Nicotine as Therapy]=== <!--T:286-->


===2021: [https://link.springer.com/article/10.1007/s12640-021-00375-5 Novel Pharmacotherapies in Parkinson’s Disease]=== <!--T:287-->
===2021: [https://link.springer.com/article/10.1007/s12640-021-00375-5 Novel Pharmacotherapies in Parkinson’s Disease]=== <!--T:287-->


===2021: [https://www.mdpi.com/1660-4601/18/2/483/htm Potential Suppressive Effect of Nicotine on the Inflammatory Response in Oral Epithelial Cells: An In Vitro Study]=== <!--T:288-->
===2021: [https://www.mdpi.com/1660-4601/18/2/483/htm Potential Suppressive Effect of Nicotine on the Inflammatory Response in Oral Epithelial Cells: An In Vitro Study]=== <!--T:288-->


===2021: [[Special:MyLanguage/Nicotine gum enhances visual processing in healthy nonsmokers|Nicotine gum enhances visual processing in healthy nonsmokers]]=== <!--T:289-->
===2021: [[Special:MyLanguage/Nicotine gum enhances visual processing in healthy nonsmokers|Nicotine gum enhances visual processing in healthy nonsmokers]]=== <!--T:289-->


===[https://www.researchgate.net/publication/325159226_Resolution_of_chronic_rhinitis_to_staphylococcus_aureus_in_a_non-smoker_who_started_to_use_glycerine_based_e-cigarettes_Antibacterial_effects_of_vaping Resolution of chronic rhinitis to staphylococcus aureus in a non-smoker who started to use glycerine based e-cigarettes: Antibacterial effects of vaping?]=== <!--T:290-->
===[https://www.researchgate.net/publication/325159226_Resolution_of_chronic_rhinitis_to_staphylococcus_aureus_in_a_non-smoker_who_started_to_use_glycerine_based_e-cigarettes_Antibacterial_effects_of_vaping Resolution of chronic rhinitis to staphylococcus aureus in a non-smoker who started to use glycerine based e-cigarettes: Antibacterial effects of vaping?]=== <!--T:290-->


===2017 [https://www.ncbi.nlm.nih.gov/pubmed/27940486 Moist smokeless tobacco (Snus) use and risk of Parkinson's disease]=== <!--T:291-->
===2017 [https://www.ncbi.nlm.nih.gov/pubmed/27940486 Moist smokeless tobacco (Snus) use and risk of Parkinson's disease]=== <!--T:291-->
Line 1,428: Line 1,407:
*Smoke-free nicotine appears to reduce the risk of Parkinson’s disease by 60%.
*Smoke-free nicotine appears to reduce the risk of Parkinson’s disease by 60%.
*different website same study? [Moist smokeless tobacco (Snus) use and risk of Parkinson’s disease|https://academic.oup.com/ije/article/46/3/872/2656164]
*different website same study? [Moist smokeless tobacco (Snus) use and risk of Parkinson’s disease|https://academic.oup.com/ije/article/46/3/872/2656164]


===2020 [https://n.neurology.org/content/neurology/94/20/e2132.full.pdf Tobacco smoking and the risk of Parkinson disease A 65-year follow-up of 30,000 male British doctors]=== <!--T:293-->
===2020 [https://n.neurology.org/content/neurology/94/20/e2132.full.pdf Tobacco smoking and the risk of Parkinson disease A 65-year follow-up of 30,000 male British doctors]=== <!--T:293-->


===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526783/ Nicotine as Therapy]=== <!--T:294-->
===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526783/ Nicotine as Therapy]=== <!--T:294-->


===Dr. Newhouse [http://mindstudy.org/news Mind Study]=== <!--T:295-->
===Dr. Newhouse [http://mindstudy.org/news Mind Study]=== <!--T:295-->


===[https://journals.sagepub.com/doi/abs/10.1177/0883073820974851?journalCode=jcna Nicotine: A Targeted Therapy for Epilepsy Due to nAChR Gene Variants]=== <!--T:296-->
===[https://journals.sagepub.com/doi/abs/10.1177/0883073820974851?journalCode=jcna Nicotine: A Targeted Therapy for Epilepsy Due to nAChR Gene Variants]=== <!--T:296-->


===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704168/ Does Nicotine Prevent Cytokine Storms in COVID-19?]=== <!--T:297-->
===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704168/ Does Nicotine Prevent Cytokine Storms in COVID-19?]=== <!--T:297-->


===[https://pubmed.ncbi.nlm.nih.gov/32595653/ Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm]=== <!--T:298-->
===[https://pubmed.ncbi.nlm.nih.gov/32595653/ Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm]=== <!--T:298-->


===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592351/ Targeting the “Cytokine Storm” for Therapeutic Benefit]=== <!--T:299-->
===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592351/ Targeting the “Cytokine Storm” for Therapeutic Benefit]=== <!--T:299-->


===2010 [https://pubmed.ncbi.nlm.nih.gov/20414766/ Meta-analysis of the acute effects of nicotine and smoking on human performance] and 2012 [https://n.neurology.org/content/78/2/91.short Nicotine treatment of mild cognitive impairment A 6-month double-blind pilot clinical trial]=== <!--T:300-->
===2010 [https://pubmed.ncbi.nlm.nih.gov/20414766/ Meta-analysis of the acute effects of nicotine and smoking on human performance] and 2012 [https://n.neurology.org/content/78/2/91.short Nicotine treatment of mild cognitive impairment A 6-month double-blind pilot clinical trial]=== <!--T:300-->
Line 1,455: Line 1,426:
<!--T:301-->
<!--T:301-->
*Clinical studies suggest some cognitive improvements as a result of nicotine.
*Clinical studies suggest some cognitive improvements as a result of nicotine.


===2021 [https://www.dovepress.com/effectiveness-and-safety-profile-of-alternative-tobacco-and-nicotine-p-peer-reviewed-fulltext-article-JMDH Effectiveness and Safety Profile of Alternative Tobacco and Nicotine Products for Smoking Reduction and Cessation: A Systematic Review]=== <!--T:302-->
===2021 [https://www.dovepress.com/effectiveness-and-safety-profile-of-alternative-tobacco-and-nicotine-p-peer-reviewed-fulltext-article-JMDH Effectiveness and Safety Profile of Alternative Tobacco and Nicotine Products for Smoking Reduction and Cessation: A Systematic Review]=== <!--T:302-->


===[https://docs.google.com/document/d/13-D2q1P0KpmZuoFBkKV4l9wUEQ-zcHfp6MAVJGoAaG4/edit?usp=sharing INNCO's List smoking cessation]=== <!--T:303-->
===[https://docs.google.com/document/d/13-D2q1P0KpmZuoFBkKV4l9wUEQ-zcHfp6MAVJGoAaG4/edit?usp=sharing INNCO's List smoking cessation]=== <!--T:303-->
Line 1,466: Line 1,434:
Started: continue @ “Among smokers who have attempted to stop without professional support, those who use e-cigarettes are more likely to report continued abstinence than those who used a licensed NRT products [i.e., nicotine patches, gum or lozenges].”
Started: continue @ “Among smokers who have attempted to stop without professional support, those who use e-cigarettes are more likely to report continued abstinence than those who used a licensed NRT products [i.e., nicotine patches, gum or lozenges].”
https://onlinelibrary.wiley.com/doi/full/10.1111/add.12623
https://onlinelibrary.wiley.com/doi/full/10.1111/add.12623


===[https://twitter.com/jkelovuori/status/1413963688709664769 Go through the links in this thread]=== <!--T:305-->
===[https://twitter.com/jkelovuori/status/1413963688709664769 Go through the links in this thread]=== <!--T:305-->